121 related articles for article (PubMed ID: 8216838)
1. Heterotransplantation of human Burkitt's lymphoma cell lines in athymic nude mice: tumor-host relationships.
McManaway ME; Marti GE; Tosato G; Liu AK; al-Nasser AA; Kiwanuka J; Magrath IT
Pathobiology; 1993; 61(3-4):164-72. PubMed ID: 8216838
[TBL] [Abstract][Full Text] [Related]
2. Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice.
Walter J; Möller P; Moldenhauer G; Schirrmacher V; Pawlita M; Wolf J
Int J Cancer; 1992 Jan; 50(2):265-73. PubMed ID: 1309726
[TBL] [Abstract][Full Text] [Related]
3. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
[TBL] [Abstract][Full Text] [Related]
4. Anti-IgM-mediated regulation of c-myc and its possible relationship to apoptosis.
Kaptein JS; Lin CK; Wang CL; Nguyen TT; Kalunta CI; Park E; Chen FS; Lad PM
J Biol Chem; 1996 Aug; 271(31):18875-84. PubMed ID: 8702548
[TBL] [Abstract][Full Text] [Related]
5. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
[TBL] [Abstract][Full Text] [Related]
6. Burkitt's lymphoma cell lines reveal different degrees of tumorigenicity in nude mice.
Gurtsevitch VE; O'Conor GT; Lenoir GM
Int J Cancer; 1988 Jan; 41(1):87-95. PubMed ID: 2826348
[TBL] [Abstract][Full Text] [Related]
7. Characterization and comparison of two newly established Epstein-Barr virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines. EBV-negative cell line with a low level of expression of ICAM-1 molecule and EBV-positive cell line with a high level of expression of ICAM-1 molecule.
Abe M; Tasaki K; Tominaga K; Fukuhara S; Imai S; Osato T; Wakasa H
Cancer; 1992 Feb; 69(3):763-71. PubMed ID: 1309680
[TBL] [Abstract][Full Text] [Related]
8. Novel genomic imbalances and chromosome translocations involving c-myc gene in Burkitt's lymphoma.
Zimonjic DB; Keck-Waggoner C; Popescu NC
Leukemia; 2001 Oct; 15(10):1582-8. PubMed ID: 11587216
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cells.
Wolf J; Draube A; Bohlen H; Jox A; Mücke S; Pawlita M; Möller P; Diehl V
Int J Cancer; 1995 Feb; 60(4):527-33. PubMed ID: 7829268
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a newly established human Burkitt's lymphoma cell line, OMA-BL-1.
Joshi SS; DeBoer JM; Strandjord SJ; Pirruccello SJ; Sanger WG; Weisenburger DD; Sharp JG
Int J Cancer; 1991 Mar; 47(5):643-8. PubMed ID: 1848532
[TBL] [Abstract][Full Text] [Related]
11. Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cells.
Cherney BW; Bhatia KG; Sgadari C; Gutierrez MI; Mostowski H; Pike SE; Gupta G; Magrath IT; Tosato G
Cancer Res; 1997 Jun; 57(12):2508-15. PubMed ID: 9192833
[TBL] [Abstract][Full Text] [Related]
12. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
Williams SA; Chang L; Buzby JS; Suen Y; Cairo MS
Leukemia; 1996 Dec; 10(12):1980-9. PubMed ID: 8946941
[TBL] [Abstract][Full Text] [Related]
13. Regressing nude mouse grafts of Burkitt's lymphoma x lymphoblastoid cell hybrids show deregulation of the c-myc gene and expression of the EBV latent membrane protein.
Wolf J; Klevenz B; Pawlita M; Komitowski D; Moldenhauer G; zur Hausen H
Int J Cancer; 1991 Jan; 47(1):99-104. PubMed ID: 1702406
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c-myc.
Boffa LC; Cutrona G; Cilli M; Matis S; Damonte G; Mariani MR; Millo E; Moroni M; Roncella S; Fedeli F; Ferrarini M
Cancer Gene Ther; 2007 Feb; 14(2):220-6. PubMed ID: 17053816
[TBL] [Abstract][Full Text] [Related]
15. Diploid human lymphoblastoid and Burkitt lymphoma cell lines: susceptibility to murine NK cells and heterotransplantation to nude mice.
McCormick KH; Giovanella BC; Klein G; Nilsson K; Stehlin JS
Int J Cancer; 1981 Oct; 28(4):455-8. PubMed ID: 6273332
[TBL] [Abstract][Full Text] [Related]
16. Relationship between DNA cross-links, cell cycle, and apoptosis in Burkitt's lymphoma cell lines differing in sensitivity to nitrogen mustard.
O'Connor PM; Wassermann K; Sarang M; Magrath I; Bohr VA; Kohn KW
Cancer Res; 1991 Dec; 51(24):6550-7. PubMed ID: 1742728
[TBL] [Abstract][Full Text] [Related]
17. Effect of nucleolin on adriamycin resistance via the regulation of B-cell lymphoma 2 expression in Burkitt's lymphoma cells.
Mei X; Chen Y; Gan D; Chen Y; Wang L; Cao Y; Wu Z; Liu W; Zhao C; Lin M; Yang T; Hu J
J Cell Physiol; 2019 Dec; 234(12):22666-22674. PubMed ID: 31127617
[TBL] [Abstract][Full Text] [Related]
18. Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis.
Guedez L; McMarlin AJ; Kingma DW; Bennett TA; Stetler-Stevenson M; Stetler-Stevenson WG
Am J Pathol; 2001 Apr; 158(4):1207-15. PubMed ID: 11290537
[TBL] [Abstract][Full Text] [Related]
19. Metastatic capacity of Burkitt's lymphoma cell lines in nude mice.
Gurtsevitch VE; Turusov VS; Lenoir GM
Exp Toxicol Pathol; 1992 Dec; 44(7):375-80. PubMed ID: 1477517
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid induces changes in c-fgr proto-oncogene mRNA levels in Burkitt's lymphoma cells.
Faulkner L; Katz DR; Brickell PM
Immunobiology; 1993 Aug; 188(4-5):460-8. PubMed ID: 8244449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
